Broker Tips
SocGen downgrades European tobacco sector
Societe Generale strategists have downgraded the European tobacco sector to 'neutral' from 'overweight' as higher US regulatory risks combine with declining US Treasury bill yields.
Credit Suisse revises Intertek target price higher on reduced geopolitical risks
Analysts at Credit Suisse upgraded their recommendation on shares of Intertek, admitting that some of the potential risks which had led them to be more cautious had not materialised.
Morrisons' convenience moves drive upgrade by HSBC
Morrisons was upgraded to ‘hold’ from ‘reduce’ on Wednesday by HSBC after the supermarket group added a new wholesale contract that it hopes will soon be worth £1bn.
Wednesday broker round-up
Hikma Pharmaceuticals: Morgan Stanley downgrades to Equal Weight with a target price of 1600p.
Liberum cuts AA target price, but reiterates 'buy'
Analysts at Liberum were undeterred in their positive view on AA's shares despite news of the ouster of its boss, Bob McKenzie, for "gross misconduct" and the company's decision to guide towards a full-year performance in-line with expectations.
Broker tips: AA Group, IAG, AstraZeneca
Analysts at Liberum were undeterred in their positive view on AA's shares despite news of the ouster of its boss, Bob McKenzie, for "gross misconduct" and the company's decision to guide towards a full-year performance in-line with expectations.
Deutsche Bank says IAG set to re-rate versus peers, reiterates 'buy'
Deutsche Bank said the recent decline in IAG's earnings per share relative to Deutsche Lufthansa and Air France-KLM was unwarranted, reiterating its 'buy' recommendation and 650. 0p target in the process.
Jefferies cuts AstraZeneca target price
Analysts at Jefferies cut their target price for AstraZeneca's shares following various updates from the company, especially as regards its MYSTIC clinical trial for its anti-lung cancer tumour treatment Imfinzi.
